Division of Reproductive Health, Research Center in Population Health, National Institute of Public Health, Cuernavaca, Mexico; Divisions of Reproductive Sciences and Neuroscience, Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.
Research Unit in Reproductive Medicine, UMAE Hospital de Ginecobstetricia "Luis Castelazo Ayala", Mexico, DF, Mexico.
Mol Cell Endocrinol. 2014 Jan 25;382(1):411-423. doi: 10.1016/j.mce.2013.06.024. Epub 2013 Jun 24.
G protein coupled receptors (GPCRs) are a large superfamily of integral cell surface plasma membrane proteins that play key roles in transducing extracellular signals, including sensory stimuli, hormones, neurotransmitters, or paracrine factors into the intracellular environment through the activation of one or more heterotrimeric G proteins. Structural alterations provoked by mutations or variations in the genes coding for GPCRs may lead to misfolding, altered plasma membrane expression of the receptor protein and frequently to disease. A number of GPCRs regulate reproductive function at different levels; these receptors include the gonadotropin-releasing hormone receptor (GnRHR) and the gonadotropin receptors (follicle-stimulating hormone receptor and luteinizing hormone receptor), which regulate the function of the pituitary-gonadal axis. Loss-of-function mutations in these receptors may lead to hypogonadotropic or hypergonadotropic hypogonadism, which encompass a broad spectrum of clinical phenotypes. In this review we describe mutations that provoke misfolding and failure of these receptors to traffick from the endoplasmic reticulum to the plasma membrane. We also discuss some aspects related to the therapeutic potential of some target-specific drugs that selectively bind to and rescue function of misfolded mutant GnRHR and gonadotropin receptors, and that represent potentially valuable strategies to treat diseases caused by inactivating mutations of these receptors.
G 蛋白偶联受体 (GPCRs) 是一个大型的细胞表面整联蛋白超家族,通过激活一个或多个异三聚体 G 蛋白,在将细胞外信号(包括感觉刺激、激素、神经递质或旁分泌因子)转导到细胞内环境中发挥关键作用。基因突变或编码 GPCRs 的基因变异引起的结构改变可能导致错误折叠、受体蛋白的质膜表达改变,并且经常导致疾病。许多 GPCRs 在不同水平上调节生殖功能;这些受体包括促性腺激素释放激素受体 (GnRHR) 和促性腺激素受体(卵泡刺激素受体和黄体生成素受体),它们调节垂体-性腺轴的功能。这些受体的功能丧失性突变可能导致促性腺激素低下或促性腺激素性性腺功能减退症,其包含广泛的临床表型。在这篇综述中,我们描述了引起这些受体错误折叠和无法从内质网运输到质膜的突变。我们还讨论了一些与一些靶向特异性药物的治疗潜力相关的方面,这些药物选择性地结合并挽救错误折叠的突变型 GnRHR 和促性腺激素受体的功能,并且代表了治疗这些受体失活突变引起的疾病的潜在有价值的策略。